Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study to Investigate if Valproate Add-on Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients

NCT00139074 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00139074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00139074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study to Investigate if Valproate Add-on Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2005
Completion date
June 30, 2006
Enrollment
17 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder